Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Prognostix, a privately-held spin out of the Cleveland Clinic Foundation, has appointed Jake Orville as its new president and CEO.
Subscribe to our email newsletter
Most recently, Mr Orville served as vice president of global sales for NextGen Sciences, an Ann Arbor, Michigan-based biomarker testing provider. Prior to joining NextGen, Mr Orville was vice president of sales and business development, and member of the senior management team at Third Wave Technologies.
Mr Orville joined Prognostix in April as a consultant. Under his leadership, the company recently closed a $1-million fundraising round with its current investors.
Vijay Aggarwal, CEO of Aureon Laboratories, said: “Jake Orville has long track record of success in the diagnostics industry and we are delighted that he will lead Prognostix at this important time in the company’s development. Jake is the right leader to guide Prognostix as the company captures valuable market opportunities and builds shareholder value.”